company

Latest News

AASLD
AI
AIH
Artificial Intelligence
Autoimmune Hepatitis
Automatical Intelligence
Awards
Biliary Disease
Biomarker
COVID-19
Clinical Trials
CoverScan
Diet
Exercise
Fatty Liver Disease
Fetal Growth Restriction (FGR)
Forbes.com
Genetics
Health
Healthtech
Hepatica
High Risk Group
Immunosppressed
International NASH Day
Liver Cancer
Liver Disease
Liver Health
Liver Patients
Liver Transplant
LiverMultiScan
LiverTwitter
Long COVID
MRCP+
MRI
Multiorgan Impairment
Multiparametric MRI
NAFLD
NASH
New Director
New Grant
New Partnership
New Publication
News
PSC
Partnership
Pathology
Patient Safety
Perspectum Diagnostics
Pharma
Population Imaging
RADIcAL
Radiology
Singapore
Stillbirth
Top 100
Type 2 Diabetes
UKBiobank
liverhealth
medtech
startedinoxford
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
2017

LITMUS Project – LiverMultiScan™ included in ground-breaking €34 million project to develop better test for liver disease

November 24, 2017

Top 100
Forbes.com
liverhealth
UKBiobank
Type 2 Diabetes
Stillbirth
startedinoxford
Singapore
Radiology
RADIcAL
PSC
Population Imaging
Pharma
Perspectum Diagnostics
Patient Safety
Pathology
Partnership
New Publication
New Partnership
New Grant
News
New Director
NASH
NAFLD
Multiparametric MRI
Multiorgan Impairment
MRI
MRCP+
medtech
Long COVID
LiverTwitter
LiverMultiScan
Liver Transplant
Liver Patients
Liver Health
Liver Disease
Liver Cancer
International NASH Day
Immunosppressed
High Risk Group
Hepatica
Healthtech
Health
Genetics
Fetal Growth Restriction (FGR)
Fatty Liver Disease
Exercise
Diet
COVID-19
CoverScan
Clinical Trials
Biomarker
Biliary Disease
Awards
Autoimmune Hepatitis
Automatical Intelligence
Artificial Intelligence
AIH
AI
AASLD
Any